OneLife SA is a Belgian biomedical company specializing in the development and production of enzymatic cleaning solutions designed to combat soiling and biofilms on medical devices and within hospital environments. The company operates within the healthcare sector, focusing on clients such as hospitals and medical facilities that require stringent hygiene standards to prevent Healthcare Acquired Infections (HAIs) and Antimicrobial Resistance (AMR). OneLife's business model revolves around creating and selling high-performance enzymatic cleaners that ensure the complete and irreversible degradation of organic soil and biofilms, thereby continuously preventing their reformation. This not only ensures the decontamination of medical devices but also contributes to optimal infection risk management. The company generates revenue through the direct sale of its cleaning solutions and possibly through partnerships and collaborations with healthcare institutions. OneLife's solutions are ISO13485 certified, indicating adherence to international standards for medical device quality management systems. The company is led by a team of experts including CEO Koen Billet and Head of Sales and Marketing Kristof Nijs, among others, who are committed to antimicrobial stewardship and adding value to healthcare by developing sustainable and scientifically driven solutions.

Keywords: Enzymatic cleaning, biofilms, medical devices, infection control, healthcare, antimicrobial resistance, hospital hygiene, ISO13485, biomedical, sustainable solutions.